1) Kato E, Sawada T, Tahara K, et al. The age at onset of rheumatoid arthritis is increasing in Japan : a nationwide database study. Int J Rheum Dis. 2017 ; 20 : 839-45.
2) Deal C L, Meenan RF, Goldenberg DL, et al. The clinical features of elderly-onset rheumatoid arthritis. A comparison with younger-onset disease of similar duration. Arthritis Rheum. 1985 ; 28 : 987-94.
3) Mueller RB, Kaegi T, Finckh A, et al. Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort. Rheumatology (Oxford). 2014 ; 53 : 671-7.
4) Oka S, Furukawa H, Shimada K, et al. Association of HLA-DRB1 genotype with younger age onset and elder age onset rheumatoid arthritis in Japanese populations. Medicine (Baltimore). 2019 ; 98 : e18218.
5) Boots A, Maier AB, Stinissen P, et al. The influence of ageing on the development and management of rheumatoid arthritis. Nat Rev Rheumatol. 2013 ; 9 : 604-13.
6) Murata K, Ito H, Hashimoto M, et al. Elderly onset of early rheumatoid arthritis is a risk factor for bone erosions, refractory to treatment : KURAMA cohort. Int J Rheum Dis. 2019 ; 22 : 1084-93.
7) Ranganath VK, Maranian P, Elashoff DA, et al. Comorbidities are associated with poorer outcomes in community patients with rheumatoid arthritis. Rheumatology (Oxford). 2013 ; 52 : 1809-17
8) Nakajima A, Inoue E, Tanaka E, et al. Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA. Scand J Rheumatol. 2010 ; 39 : 360-7.
10) Salaffi F, Di Carlo M, Farah S, et al. Prevalence of frailty and its associated factors in patients with rheumatoid arthritis : a cross-sectional analysis. Clin Rheumatol. 2019 ; 38 : 1823-30.
11) Torii M, Hashimoto M, Hanai A, et al. Prevalence and factors associated with sarcopenia in patients with rheumatoid arthritis. Mod Rheumatol. 2019 ; 29 : 589-95.
12) Sugihara T, Ishizaki T, Hosoya T, et al. Structural and functional outcomes of a therapeutic strategy targeting low disease activity in patients with elderly-onset rheumatoid arthritis : a prospective cohort study (CRANE). Rheumatology 2015 ; 54 : 798-807
13) Schneeweiss S, Setoguchi S, Weinblatt M, et al. Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis. Arthritis Rheum. 2007 ; 56 : 1754-64.
14) Murota A, Kaneko Y, Yamaoka K, et al. Safety of biologic agents in elderly patients with rheumatoid arthritis. J Rheumatol. 2016 ; 43 : 1984-8.
15) Bechman K, Oke A, Yates M, et al. Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British Society for Rheumatology Biologics Register. Rheumatology (Oxford). 2020 ; 59 : 2563-71.
16) 葛谷雅文. 老年医学におけるSarcopenia & Frailtyの重要性. 日本老年医学会雑誌. 2009 ; 46 : 279-85.